We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves

By HospiMedica International staff writers
Posted on 04 Aug 2020
A group of researchers have formed the Rapid Deployment Vaccine Collaborative (RaDVaC), developed their own do-it-yourself COVID-19 vaccine and begun testing the vaccine on themselves.

RaDVaC members come from a range of backgrounds and professions, but most of them are trained scientists and engineers. This expanding core group met through their associations with Harvard Medical School and HMS Professor George Church. The project was launched in the Boston area but is expanding steadily across the US and throughout the world.

Image: Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves (Photo courtesy of RaDVaC)
Image: Researchers Testing Do-It-Yourself COVID-19 Vaccine on Themselves (Photo courtesy of RaDVaC)

RaDVaC’s mission is rapid development, testing, and public sharing of vaccine recipes that are simple enough to be produced and administered by individual citizen scientists and qualified healthcare professionals. The group of researchers has drawn on decades of scientific literature describing proven vaccine designs to develop, produce, and self-administer an intranasally delivered vaccine. RaDVaC members have designed, produced, and self-administered several progressive generations of nasal vaccines against SARS-CoV-2. Currently, over 20 of them have self-administered the vaccine which is made up of fragments (peptides) of the virus, similar to the ones already being used for hepatitis B and human papillomavirus.

The group has not filed any patents or other intellectual property protections, and all information on their vaccine designs, material procurement, production, self-administration, and testing are freely shared on their website. In addition to publicly releasing the results of our vaccine work, RaDVaC is working with other researchers to advance new kinds of testing to assess immunity. The group aims to motivate others around the world to build on their efforts, to share their research openly, and to deploy protective vaccines rapidly and safely.


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Needlefree Closed System Transfer Device
ChemoClave

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles